Zimmer Biomet prez, CEO Dvorak unexpectedly resigns | Personnel Moves, July 12, 2017

Zimmer Biomet (NYSE:ZBH) said late yesterday its prez and CEO David Dvorak has resigned from his position at the head of the company, effective immediately, to be replaced on an interim basis by senior VP and CFO Daniel Florin until a permanent successor is named. The Warsaw, Ind.-based company said it is retaining “a leading executive search firm” as it pursues a new candidate to permanently fill the CEO role. “Serving alongside Zimmer Biomet’s dedicated employees over the past 16 years and leading the company as CEO for ten of those years has been a privilege and a highlight of my professional career. Our collective efforts grew employment from approximately 3,000 in 2001 to 18,000 today and built a Fortune 500 company. I am particularly proud of what we have accomplished working together with surgeons and clinicians to help millions of patients globally improve their quality of life,” Dvorak said in a press release. “During David’s 10-year tenure as CEO, Zimmer Biomet has transformed into a truly global leader in musculoskeletal healthcare. Through a combination of organic growth and strategic acquisitions, Zimmer Biomet’s revenue has doubled and the company has established a leading portfolio of technologies, solutions and personalized services. With this strong platform in place, there is tremendous opportunity for Zimmer Biomet. On behalf of the board, I thank David for his many important contributions to our company and...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Abiomed Accuray Inc. Amendia Boston Scientific Cochlear Ltd. conformis crbard GE Healthcare InVivo Corp. IsoRay johnsonandjohnson Lidco Lumicell Neurometrix portal instruments RenalGuard Solutions Source Type: news